Europe PMC
open access
Emerging therapeutic strategies for medication-related osteonecrosis of the jaw: From microenvironmental modulation to precision medicine (Review)
Medication-related osteonecrosis of the jaw (MRONJ) is a challenging complication associated primarily with antiresorptive and antiangiogenic therapies. Its pathogenesis involves a complex interplay of impaired bone remodeling, angiogenesis, inflammation and infection, immune regulation and soft tis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Retrospective Cohort Study of Medication-Related Osteonecrosis of the Jaw (MRONJ) Prevention.#659577
- Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)#1260667
- Immunological Parameters Between MRONJ Stages#844835
- Therapeutic Exposures and Risk Factors in MRONJ#1096497
- Initial Management of MRONJ Stages I and II, a Clinical Trial With Detection of Salivary Biomarkers#852315
Record · ID 1469526
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive